Ligand validation:3NWF

MRY: MESO-ERYTHRITOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3NWF_MRY_B_4000	65%	61%	0.144	0.945	0.61	0.87	-	-	3	0	100%	1
3NWF_MRY_A_4000	28%	60%	0.259	0.912	0.57	0.94	-	-	0	0	100%	1
3NWA_MRY_D_2000	85%	66%	0.117	0.982	0.48	0.81	-	-	0	0	100%	1
3NWD_MRY_C_2001	58%	86%	0.168	0.946	0.38	0.34	-	-	1	0	100%	1
3NW8_MRY_A_731	52%	74%	0.181	0.94	0.31	0.69	-	-	0	0	100%	1
4HSI_MRY_A_804	40%	67%	0.233	0.944	0.39	0.87	-	-	0	0	100%	1
5U5F_MRY_B_301	97%	73%	0.06	0.976	0.29	0.74	-	-	0	0	100%	1
5HHF_MRY_C_605	87%	46%	0.08	0.953	0.65	1.4	-	2	0	0	100%	1
1XR2_MRY_A_1205	81%	82%	0.082	0.934	0.32	0.47	-	-	0	0	100%	1
3FSU_MRY_C_5320	78%	44%	0.081	0.923	0.87	1.28	-	2	0	0	100%	1
1T7L_MRY_B_1352	71%	81%	0.092	0.913	0.32	0.49	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.